Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001680329-26-000002

Director sold 734 shares at $76.00 ($55,784)

  • Director acquired 734 shares (option exercise)
  • Director acquired 4,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Reeve Emma · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Grant or award : show line 1 in the form 10b5-1 +4,000 10,666 D
2026-01-05 Exercise or conversion : show line 2 in the form 10b5-1 +734 $46.54 $34,160 11,400 D
2026-01-05 Sale : show line 3 in the form 10b5-1 −734 $76.00 $55,784 10,666 D
Open-market sales · 734 sh · avg $76.00 · $55,784

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) +3,475 3,475 D
2026-01-05 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −734 0 D
Loading xslF345X05/form4-01062026_050117.xml…